Editorial: The progress of rare lesions of the sellar region

Front Endocrinol (Lausanne). 2022 Aug 24:13:978284. doi: 10.3389/fendo.2022.978284. eCollection 2022.

Authors

Congxin Dai¹, Run Yu², Haijun Wang³, Justo P Castaño⁴

Affiliations

¹ Department of Neurosurgery, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
² David Geffen School of Medicine, University of California, Los Angeles, CA, United States.
³ Department of Neurosurgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
⁴ Maimonides Biomedical Research Institute of Córdoba (IMIBIC), Reina Sofia University Hospital, CIBERobn, University of Córdoba, Córdoba, Spain.

No abstract available

Keywords: chemotherapy; diagnostic molecular markers; pathogenesis; radiotherapy; rare lesions of the sellar region; surgery; targeted therapies.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Humans
Pituitary Neoplasms* / pathology
Sella Turcica* / diagnostic imaging
Sella Turcica* / pathology